Paragonix Technologies
Christopher Tomosivitch has extensive financial leadership experience, having served as Chief Financial Officer at Paragonix Technologies, Inc., Allurion Technologies, and Boston Heart Diagnostics. Additionally, Christopher held a dual role at Haemonetics as Vice President of Finance for Europe and Emerging Markets and General Manager of the Software Business, as well as serving as Director of Finance for the Patient Division and Global Sales. Christopher's academic background includes a BA in Economics and Politics from Fairfield University and an MBA in Finance from the University of Delaware's Lerner College of Business and Economics.